ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,213Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 3593

$1.17M Total Retail Price of All Prescriptions

Rank: 93 out of 3593

842 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 842 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 842 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 13,624 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 862 477 1 2
HYDROCODONE-ACETAMINOPHEN 841 324 S3 2 7
AMLODIPINE BESYLATE 810 451 3 3
SIMVASTATIN 794 447 4 1
POTASSIUM CHLORIDE 768 362 5 24
OMEPRAZOLE 767 398 6 5
METFORMIN HCL 742 343 7 6
FUROSEMIDE 720 373 8 9
GABAPENTIN 523 189 9 16
CARVEDILOL 511 312 10 23
LEVOTHYROXINE SODIUM 479 321 11 4
CLONIDINE HCL 428 163 12 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 382 215 13 26
HYDROCHLOROTHIAZIDE 352 169 14 10
ATENOLOL 341 118 15 11
PRAVASTATIN SODIUM 336 197 16 13
METOPROLOL TARTRATE 336 191 16 8
IBUPROFEN 333 115 18 43
ZOLPIDEM TARTRATE 310 122 19 12
PROAIR HFA 306 89 20 54
CRESTOR 293 159 21 21
AMLODIPINE BESYLATE-BENAZEPRIL 283 180 22 65
NIFEDIPINE ER 280 171 23 75
LOVASTATIN 278 203 24 20
ATORVASTATIN CALCIUM 275 200 25 15
RANITIDINE HCL 263 156 26 27
GLIMEPIRIDE 253 191 27 44
ALPRAZOLAM 253 83 27 37
CITALOPRAM HBR 249 81 29 25
MELOXICAM 242 126 30 29
LOSARTAN POTASSIUM 221 130 31 14
LANTUS 216 129 32 57
SERTRALINE HCL 214 55 33 28
BACLOFEN 207 102 34 109
DIOVAN 206 162 35 46
HYDRALAZINE HCL 206 108 35 107
AZITHROMYCIN 203 87 37 34
CLOPIDOGREL 184 90 38 30
ALENDRONATE SODIUM 182 148 39 22
VERAPAMIL ER 174 84 40 99
METHYLPREDNISOLONE 173 71 41 103
ALLOPURINOL 169 108 42 35
WARFARIN SODIUM 169 97 42 18
CYCLOBENZAPRINE HCL 168 44 R 44 72
LABETALOL HCL 161 60 45 220
TRAMADOL HCL 160 101 46 17
OXYCODONE HCL-ACETAMINOPHEN 158 45 S2 47 82
GLYBURIDE 157 86 R 48 55
NAPROXEN 151 56 49 68
ADVAIR DISKUS 149 44 50 47
FLUTICASONE PROPIONATE 147 40 51 32
CIPROFLOXACIN HCL 146 67 52 52
METOPROLOL SUCCINATE 142 89 53 19
PREDNISONE 137 65 54 49
RISPERIDONE 134 75 55 83
SINGULAIR 132 44 56 77
VENTOLIN HFA 130 49 57 80
GLIPIZIDE 129 76 58 40
DIOVAN HCT 128 53 59 76
TRAZODONE HCL 127 46 60 53
AMOXICILLIN 124 41 61 128
NOVOLIN 70-30 123 57 62 146
PLAVIX 116 58 63 42
BENAZEPRIL HCL 115 58 64 69
LANTUS SOLOSTAR 113 37 65 122
DONEPEZIL HCL 113 113 65 31
ENALAPRIL MALEATE 113 62 65 38
OXYCODONE-ACETAMINOPHEN 110 33 S2 68 93
ISOSORBIDE MONONITRATE ER 107 84 69 61
AMOX TR-POTASSIUM CLAVULANATE 103 41 70 138
DOXYCYCLINE HYCLATE 101 49 71 141
GEMFIBROZIL 98 59 72 88
COMBIVENT 95 39 73 161
INSULIN SYRINGE 95 46 73 91
FAMOTIDINE 94 45 75 70
TRIAMTERENE-HCTZ 93 56 76 66
GLIPIZIDE XL 92 34 77 179
ACETAMINOPHEN-CODEINE 91 33 S3 78 153
MONTELUKAST SODIUM 91 28 78 151
CARISOPRODOL 89 0 R 80 97
NEXIUM 89 38 80 36
FLUCONAZOLE 88 0 82 229
OXYCODONE HCL 87 37 S2 83 59
OXYBUTYNIN CHLORIDE 87 45 83 104
PAROXETINE HCL 87 33 83 62
PANTOPRAZOLE SODIUM 85 18 86 45
ATENOLOL-CHLORTHALIDONE 85 62 86 191
CAPTOPRIL 84 43 88 213
AMITRIPTYLINE HCL 83 40 R 89 90
DILTIAZEM ER 82 46 90 194
SYMBICORT 81 23 91 160
ACYCLOVIR 80 13 92 259
METRONIDAZOLE 78 0 93 268
METHOTREXATE 76 34 94 354
TAMSULOSIN HCL 76 50 94 33
LOSARTAN-HYDROCHLOROTHIAZIDE 74 42 96 48
LIPITOR 72 49 97 136
MECLIZINE HCL 72 26 97 96
KLOR-CON 10 71 51 99 114
FLUOXETINE HCL 70 23 100 60
MIRTAZAPINE 69 59 101 64
FLOVENT HFA 69 25 101 303
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 28 101 102
NAMENDA 68 66 104 50
SURE COMFORT 67 33 105 159
ACTOS 65 49 106 133
TERAZOSIN HCL 64 45 107 115
METOCLOPRAMIDE HCL 64 22 107 145
SYNTHROID 61 61 109 51
LORAZEPAM 59 24 110 98
PHENYTOIN SODIUM EXTENDED 59 30 110 165
TEMAZEPAM 57 24 112 56
GLIPIZIDE ER 57 24 112 101
KETOCONAZOLE 56 16 114 118
DIAZEPAM 56 0 114 252
HUMULIN 70-30 56 33 114 215
LEVEMIR FLEXPEN 54 18 117 228
QUINAPRIL HCL 53 40 118 219
NYSTATIN 52 16 119 167
CYMBALTA 52 29 119 73
METHOCARBAMOL 50 0 R 121 185
PEN NEEDLE 50 14 121 188
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.